Impact of COVID-19 on Influenza and Pneumococcal Vaccination of Psoriatic Patients in Germany: Results from Vac-Pso DOI Creative Commons
Christian Kromer,

Phoebe Wellmann,

Daniel Kromer

et al.

Vaccines, Journal Year: 2024, Volume and Issue: 12(6), P. 614 - 614

Published: June 4, 2024

Background: Suboptimal influenza and pneumococcal vaccination rates have been reported before the COVID-19 pandemics in certain populations at risk for severe infection. The aim of this longitudinal cohort study was to investigate changes patient perceptions patients with psoriasis (PsO) during pandemic. Methods: Data on vaccination, disease characteristics, comorbidity, were collected questionnaires pandemic approximately one year later. Results: Over whole who participated follow-up visit (n = 287; 59.2% male; mean age: 56.3 years), both lifetime prevalences increased significantly from 50.5% 66.2% 16.0% 41.5%, respectively. A total 88.5% PsO interested a or had already received it. reasons against vaccinations changed Conclusions: Despite promising increase prevalence our cohort, it remains important that awareness is encouraged closely monitored future research, particularly risk.

Language: Английский

The association between healthcare access and shingles vaccination among older adults in Virginia, United States DOI Creative Commons
Chidozie Declan Iwu,

Pramita Shrestha,

Alyson J. Littman

et al.

PLoS ONE, Journal Year: 2025, Volume and Issue: 20(4), P. e0316429 - e0316429

Published: April 15, 2025

Introduction Shingles is a debilitating vaccine preventable disease that poses health threat to older adults. However, the uptake of shingles vaccines remains low, and factors contributing low are not clearly understood. This study assessed association between healthcare access vaccination among adults, as well impact COVID-19 pandemic on uptake. Methods was cross-sectional adults 50 + years in Virginia (n = 16,576) using data from Behavioral Risk Factor Surveillance System (2018, 2019, 2021). We calculated prevalence by insurance primary care provider (used proxies for access) relation (pre vs during). Log binomial regression models were used estimate ratios (PR), adjusting confounders. Results substantially higher those with compared without. Specifically, 35% vs. 10% without (adjusted PR (aPR): 2.03, 95% CI 1.44, 2.86), 36% 15% (aPR: 1.99, CI: 1.65-2.41). Finally, 41% during 30% before (aPR:1.26, 1.20–1.33). Conclusion Individuals significantly more likely receive such access. Moreover, period pandemic.

Language: Английский

Citations

0
Impact of COVID-19 on Influenza and Pneumococcal Vaccination of Psoriatic Patients in Germany: Results from Vac-Pso DOI Creative Commons
Christian Kromer,

Phoebe Wellmann,

Daniel Kromer

et al.

Vaccines, Journal Year: 2024, Volume and Issue: 12(6), P. 614 - 614

Published: June 4, 2024

Background: Suboptimal influenza and pneumococcal vaccination rates have been reported before the COVID-19 pandemics in certain populations at risk for severe infection. The aim of this longitudinal cohort study was to investigate changes patient perceptions patients with psoriasis (PsO) during pandemic. Methods: Data on vaccination, disease characteristics, comorbidity, were collected questionnaires pandemic approximately one year later. Results: Over whole who participated follow-up visit (n = 287; 59.2% male; mean age: 56.3 years), both lifetime prevalences increased significantly from 50.5% 66.2% 16.0% 41.5%, respectively. A total 88.5% PsO interested a or had already received it. reasons against vaccinations changed Conclusions: Despite promising increase prevalence our cohort, it remains important that awareness is encouraged closely monitored future research, particularly risk.

Language: Английский

Citations

0